Establishment Labs Holdings Inc Cash Flow Conversion Efficiency
Establishment Labs Holdings Inc cash flow conversion efficiency. Based on the latest financial reports, Establishment Labs Holdings Inc (ESTA) has a cash flow conversion efficiency ratio of -0.768x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-16.60 Million) by net assets ($21.61 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Establishment Labs Holdings Inc (2016–2025)
Cash flow conversion efficiency of Establishment Labs Holdings Inc from 2016 to 2025. This chart illustrates how Establishment Labs Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Establishment Labs Holdings Inc share price for real-time trading data and today's change.
Establishment Labs Holdings Inc Cash Flow Conversion Ratio Explained
Establishment Labs Holdings Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Establishment Labs Holdings Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Establishment Labs Holdings Inc ranked by their cash flow conversion efficiency. Also see Establishment Labs Holdings Inc stock valuation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Imax Corp
NYSE:IMAX
|
0.009x |
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SHG:603882
|
0.050x |
|
Smartfit Escola de Ginástica e Dança S.A
SA:SMFT3
|
0.059x |
|
COUNTRY GARDEN SVDL-0001
F:75H
|
N/A |
|
TKH Group NV
AS:TWEKA
|
0.168x |
|
Innovex International, Inc
NYSE:INVX
|
0.019x |
|
Jiangsu Dingsheng New Material Joint-Stock Co Ltd
SHG:603876
|
0.012x |
|
BlackRock Science and Technology Trust II
NYSE:BSTZ
|
-0.019x |
Annual Cash Flow Conversion Efficiency for Establishment Labs Holdings Inc (2016–2025)
The table below shows the annual cash flow conversion efficiency of Establishment Labs Holdings Inc from 2016 to 2025. Review free cash flow generation of Establishment Labs Holdings Inc to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $23.55 Million | $-50.89 Million | -2.161x | -96.10% |
| 2024-12-31 | $53.09 Million | $-58.52 Million | -1.102x | +77.10% |
| 2023-12-31 | $18.39 Million | $-88.51 Million | -4.812x | -175.50% |
| 2022-12-31 | $-8.19 Million | $-52.17 Million | 6.373x | +1274.55% |
| 2021-12-31 | $50.74 Million | $-27.53 Million | -0.543x | -225.14% |
| 2020-12-31 | $74.96 Million | $-12.51 Million | -0.167x | +77.95% |
| 2019-12-31 | $39.61 Million | $-29.98 Million | -0.757x | -55.21% |
| 2018-12-31 | $69.48 Million | $-33.88 Million | -0.488x | -107.65% |
| 2017-12-31 | $-5.01 Million | $-31.97 Million | 6.377x | +1081.74% |
| 2016-12-31 | $-26.43 Million | $-14.27 Million | 0.540x | -- |
About Establishment Labs Holdings Inc
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products… Read more